Quick Answer
MapLight Therapeutics, Inc. reported Total Assets of $479.51 million for fiscal year 2025.
MapLight Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $479.51M | +250.2% |
| 2024 | $136.92M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $257.22M | — | +87.9% |
| December 31, 2024 | $136.92M | — | — |
- MapLight Therapeutics, Inc. showed an increase of +250.2% in Total Assets compared to the prior fiscal year.
- Over the 2024–2025 period, MapLight Therapeutics, Inc.’s total assets has grown by 250.2% (from $136.92 million to $479.51 million).
- The most recent figure is from MapLight Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: